{"id":2209,"date":"2024-02-27T12:28:34","date_gmt":"2024-02-27T12:28:34","guid":{"rendered":"https:\/\/www.axxessbio.com\/?p=2209"},"modified":"2024-02-27T13:10:19","modified_gmt":"2024-02-27T13:10:19","slug":"gencebok-caffeine-citrate-for-apnoea-of-prematurity-is-now-approved-in-singapore","status":"publish","type":"post","link":"https:\/\/www.axxessbio.com\/?p=2209","title":{"rendered":"GENCEBOK\u00ae (caffeine citrate) for apnoea of prematurity is now approved in Singapore"},"content":{"rendered":"\n<p>AxxessBio is pleased to share that GENCEBOK\u00ae (caffeine citrate) 10 MG\/ML SOLUTION FOR INFUSION has been approved by the Health Sciences Authority (HSA) Singapore for apnoea of prematurity.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<ul>\n<li>Treatment of primary apnoea of premature newborns<br><br><\/li>\n<\/ul>\n\n\n\n<p>GENCEBOK\u00ae is the first caffeine citrate approved in Singapore for above indication.<\/p>\n\n\n\n<p>GENCEBOK\u00ae was also granted the European Marketing Authorization (EMA) in Aug 2020.<\/p>\n\n\n\n<p>GENCEBOK\u00ae has the following features providing the convenience of administration and accessibility:<\/p>\n\n\n\n<ul>\n<li>Solution can be used intravenously and orally<\/li>\n\n\n\n<li>Optimal concentration for maintenance dose<\/li>\n\n\n\n<li>Pharmaceutical-grade single-use ampoule<\/li>\n\n\n\n<li>Room temperature storage<\/li>\n\n\n\n<li>Long shelf life up to 3 years<br><br><\/li>\n<\/ul>\n\n\n\n<p>Caffeine citrate is recommended by the World Health Organization for the treatment of apnoea in preterm infants &lt;37 weeks\u2019 gestation.<\/p>\n\n\n\n<p><\/p>\n\n\n\n<p><br><em>*Please refer to the local package insert for full prescribing information.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>AxxessBio is pleased to share that GENCEBOK\u00ae (caffeine citrate) 10 MG\/ML SOLUTION FOR INFUSION has been approved by the Health Sciences Authority (HSA) Singapore for apnoea of prematurity. GENCEBOK\u00ae is the first caffeine citrate approved in Singapore for above indication. GENCEBOK\u00ae was also granted the European Marketing Authorization (EMA) in Aug 2020. GENCEBOK\u00ae has the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2216,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=\/wp\/v2\/posts\/2209"}],"collection":[{"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2209"}],"version-history":[{"count":8,"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=\/wp\/v2\/posts\/2209\/revisions"}],"predecessor-version":[{"id":2222,"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=\/wp\/v2\/posts\/2209\/revisions\/2222"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=\/wp\/v2\/media\/2216"}],"wp:attachment":[{"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2209"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2209"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.axxessbio.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2209"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}